2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
2
Gastrointestinal
2
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
26
Precursor Cell Lymphoblastic Leukemia-Lymphoma
24
Leukemia
12
Leukemia, Myeloid, Chronic-Phase
7
Leukemia, Myeloid, Acute
7
Blast Crisis
7
Neoplasms
6
Leukemia, Myeloid, Accelerated Phase
6
Myeloproliferative Disorders
5
Carcinoma, Non-Small-Cell Lung
5
Neoplasms by Histologic Type
4
Leukemia, Myeloid
4
Hematologic Diseases
4
Bone Marrow Diseases
4
Myelodysplastic Syndromes
2
Lymphoproliferative Disorders
2
Lymphatic Diseases
2
Leukemia, Myelomonocytic, Chronic
2
Immunoproliferative Disorders
2
Immune System Diseases
2
Hematologic Neoplasms
2
Gastrointestinal Stromal Tumors
2
Gastrointestinal Neoplasms
2
Breast Neoplasms
2
Thyroid Neoplasms
1
Thrombocytosis
1
Small Cell Lung Carcinoma
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Piebaldism
1
Interventions
Imatinib Mesylate
71
Sunitinib
31
regorafenib
17
nilotinib
15
ripretinib
13
avapritinib
7
Laparoscopy
5
Ipilimumab
5
Dasatinib
5
spartalizumab
4
CTLA-4 Antigen
4
Blood Specimen Collection
4
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
4
pexidartinib
3
pazopanib
3
binimetinib
3
Temozolomide
3
Surveys and Questionnaires
3
Surgical Procedures, Operative
3
Paclitaxel
3
Oxaliplatin
3
Observation
3
Nivolumab
3
Midazolam
3
Leucovorin
3
Gemcitabine
3
Biopsy
3
Bevacizumab
3
trametinib
2
tanespimycin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Gastrointestinal Stromal Tumors
×
ponatinib
×
Clear all
NCT01874665
2018-05-18
GIST
Takeda
Phase 2
Completed
45 enrolled
21 charts
NCT03171389
2017-05-31
POETIG
Universität Duisburg-Essen
Phase 2
Unknown
81 enrolled